Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - Implication in modification of radiationdamage

Redox Biology

Volumn 2, Issue 1, 2014, Pages 832-846

  Anuranjani, ^a   Bala, Madhu ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

HMGB1; MRN complex; Nrf2 ARE pathway; Radio modification; TWEAK

Indexed keywords

GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; MRE11 PROTEIN; NIBRIN; RAD50 PROTEIN; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FREE RADICAL; KELCH LIKE ECH ASSOCIATED PROTEIN 1; REACTIVE OXYGEN METABOLITE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

DNA REPAIR; DNA STRAND BREAKAGE; HUMAN; IMMUNOMODULATION; INFLAMMATION; IONIZING RADIATION; MOLECULAR INTERACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RADIATION INJURY REPAIR; RADIATION PROTECTION; RADIATION RESPONSE; REVIEW; ANTIOXIDANT RESPONSIVE ELEMENT; DOUBLE STRANDED DNA BREAK; IMMUNE DEFICIENCY; IONIZATION; NONHUMAN; PROTEIN INTERACTION; RADIATION DOSE; RADIATION INJURY; RADIOLYSIS; SINGLE STRANDED DNA BREAK; CHEMISTRY; DNA DAMAGE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTIOXIDANT RESPONSE ELEMENTS; CELL CYCLE PROTEINS; CYTOKINES; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HMGB1 PROTEIN; HUMANS; NF-E2-RELATED FACTOR 2; SIGNAL TRANSDUCTION;

EID: 84903514856     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.02.008     Document Type: Review

References (159)

1. Hall E.J., Amato G.J., Radiobiology for the Radiologist. Seventh edition, ISBN 978-1-60831-193-4.
2. Douki T., Cadet J. Radiation - induced damage to DNA: from model compounds to cell. Radiation Chemistry: From Basics to Applications in Material and Life Sciences 2008, EDP Sciences, Paris. M. Spothem-Maurizot, M. Mostafavi, T. Douki, J. Belloni (Eds.).
3. Hallahan D.E., Spriggs D.R., Beckett M.A., Kufe D.W., et al. Increased tumor necrosis factor α mRNA after cellular exposure to IR. Proceedings of the National Academy of Sciences of the United States of America 1989, 86(24):10104-10107. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.86.24.10104.
4. Berthelot F., Fattoum L., Casulli S., Gozlan J., Marechal V., Elbim C. The effect of HMGB1, a damage associated molecular pattern molecule on polymorphonuclear neutrophil migration depends on its concentration. Journal of Innate Immunity 2012, 4:41-58. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1159/000328798.
5. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Review: free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 2007, 39(1):44-84. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.biocel.2006.07.001.
6. Natarajan M., Gibbons C.F., Mohan S., Moore S., Kadhim M.A. Oxidative stress signalling:a potential mediator of TNF-α induced genomic stability in primary vascular endothelial cells. British Journal of Radiology 2007, 80:S13-S22. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1259/bjr/15316848.
7. Kruman I., Annadora J., Bruce-Keller B.D., Naeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress mediated neuronal apoptosis. Journal of the Neurological Sciences 1997, 17(13):5089-5100.
8. + dependent isocitrate dehydrogenase. Journal of Biological Chemistry 2007, 282(18):13385-13394. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M700303200.
9. Johar D., Roth J.C., Bay G.H., Walker J.N., Kroczak T.J., Los M. Inflammatory response, reactive oxygen species, programmed cell death (necrotic like and apoptosis) cell death and cancer. Roczniki Akademii Medycznej w Bialymstoku 2004, 49:31-39.
10. Herrero A., Barja G. Sites and mechanisms responsible for the low rate of free radical production of heart mitochondria in the long lived pigeon. Mechanisms of Ageing and Development 1997, 98(2):95-111. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0047-6374(97)00076-6.
11. o site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Archives of Biochemistry and Biophysics 2003, 414(1):59-66. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0003-9861(03)00166-8.
12. Romanako A., Morimura A., Wanibuchi H., Wei M., Zaparin W., et al. Urinary bladder lesions induced by persistent chronic low dose ionizing radiations. Cancer Research 2003, 94(4):328-333.
13. Kunwar A., Priyadarshini K.I. Review "Free radicals, oxidative stress and importance of antioxidants in human health". Journal of the History of Medicine and Allied Sciences 2011, 1(2):53-60.
14. Traber M.G., Stevens J.F. Vitamin C and E: beneficial effects from a mechanistic perspective. Free Radical Biology and Medicine 2011, 51(5):1000-1013. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.freeradbiomed.2011.05.017.
15. Michalak A. Review: phenolic compounds and their antioxidant activity in plants growing under heavy metal stress. Polish Journal of Environmental Studies 2006, 15(4):523-530.
16. Maliakal P., Sankpal U.T., Basha R., Maliakal C., Ledford A., Wanwimolruk S. Relevance of drug metabolizing enzyme activity modulation by tea polyphenols in the inhibition of esophageal tumorigenesis. Medicinal Chemistry (Shāriqah (United Arab Emirates)) 2011, 7(5):480-487. http://www.ncbi.nlm.nih.gov/pubmed/, 10.2174/157340611796799096.
17. Koga K., Taguchi A., Koshimizu S., Suwa Y., Yamada Y., Shirasaka N., Yoshizumi H. Reactive oxygen scavenging activity of matured whiskey and its active polyphenols. Journal of Food Science 2007, 72(3):S212-S217. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1111/j.1750-3841.2007.00311.x.
18. Kobayashi M., Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidantsand Redox Signaling 2005, 7(3-4):385-394. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/ars.2005.7.385.
19. Mohler J., Mahaffey J.W., Deutsch E., Vani K. Control of Drosophila head segment identity by bZip homeotic gene cnc. Development (Cambridge, England) 1995, 121(1):237-247. http://www.ncbi.nlm.nih.gov/pubmed/.
20. Chan J.Y., Han X.L., Kan Y.W. Cloning of Nrf1, an NF-E2 related transcription factor, by genetic selection in yeast. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(23):11371-11375. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.90.23.11371.
21. Moi P., Chan K., Asunis I., Cao A., Kan Y.W. Isolation of NF-E2 related factor-2 (Nrf2), a NF-E2 like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(21):9926-9930. 10.1073/pnas.91.21.9926.
22. Chan J.Y., Kwong M., Lu R., Chang J., Wang B., Yen T.S., Kan Y.W. Targeted disruption of the ubiquitous CNC-bZip transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO Journal 1998, 17(6):1779-1787. http://www.ncbi.nlm.nih.gov/pubmed/.
23. Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and fras 1 negatively regulate the human antioxidant response element mediated expression of NAD(P)H quinone oxidoreductase 1 gene. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(25):14960-14965. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.93.25.14960.
24. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino terminal Neh2 domain. Genes and Development 1999, 13(1):76-86. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1101/gad.13.1.76.
25. Itoh K., Chiba T., Takahashi K., Ishii T., Igarashi K., Katoh Y., et al. Review: an Nrf2/ small Maf heterodimer mediates the induction of phase II detoxifying enzymes genes through antioxidant response elements. Biochemical and Biophysicsical Research Communications 1997, 236(2):313-322. 10.1006/bbrc.1997.6943.
26. Motohashi H., Katsuoka F., Engel J.D., Yamamoto M. Small Maf proteins serve as transcriptional Co-factor for keratinocytes differentiation in the Keap1-Nrf2 regulatory pathway. Proceedings of the National Academy of the United States of America 2004, 101(17):6379-6384. 10.1073/pnas.0305902101.
27. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. Journal of Biological Chemistry 1991, 266(18):11632-11639. http://www.ncbi.nlm.nih.gov/pubmed/.
28. Reisman S.A., Yeager R.L., Yamamoto M., Klaassen C.D. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. Toxicological Sciences : An Official Journal of the Society of Toxicology 2009, 108(1):35-47. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1093/toxsci/kfn267.
29. Mani M., Khaghani S., Mohammadi T.G., Zamani Z., Azadmanesh K., Meshkani R., et al. Activation of Nrf2-Antioxidant Response Element mediated glutamate cysteine ligase expression in hepatoma cell line by homocysteine. Hepatitis Monthly 2013, 13(5):e8394.
30. Favreau L.V., Pickett C.B. The rat quinone reductase antioxidant response element-identification of nucleotide sequence required for basal and inducible activity and detection of ARE binding proteins in hepatoma and non-hepatoma cell lines. Journal of Biological Chemistry 1995, 270(41):24468-24474. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.270.41.24468.
31. Malhotra D., Portales-Casamar E., Singh A., Srivastava S., Arenillas D., Happel C., et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through chip-sequencing profiling and network analysis. Nucleic Acids Research 2010, 38(17):5718-5734. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1093/nar/gkq212.
32. McMahon M., Itoh K., Yamamoto M., Hayes J.D. Keap1 dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of ARE-driven gene expression. Journal of Biological Chemistry 2003, 278:21592-21600. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M300931200.
33. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 function as an adaptor for Cul3 based E3 ligase to regulate proteasomal degradation of Nrf2. Molecular and Cellular Biology 2004, 24(16):7130-7139. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.24.16.7130-7139.2004.
34. Sekhar K.R., Yan X.X., Freeman M.L. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene 2002, 21(44):6829-6834. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.onc.1205905.
35. Dhakshinamoorthy S., Jaiswal A.K. Functional characterization and role of Nrf2 in ARE-mediated expression and antioxidant induction of NAD(P)H:Quinone oxidoreductase 1 gene. Oncogene 2001, 20(29):3906-3917. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.onc.1204506.
36. Bloom D.A., Dhakshinamoorthy S., Jaiswal A.K. Site directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decrease its capacity to upregulate ARE mediated expression and antioxidant induction of NAD(P)H:Quinone oxidoreductase 1 gene. Oncogene 2002, 21(14):2191-2200. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.onc.1205288.
37. Tong K.I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M. Keap1 recruits a Neh2 through binding to ETGE and DLG motifs: characterization of the two sites molecular recognition model. Molecular and Cellular Biology 2006, 26(8):2887-2900. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.26.8.2887-2900.2006.
38. Katoh Y., Itoh K., Yoshida E., Miyagishi M., Fukamizu A., Yamamoto M. Two domains of Nrf2 cooperately binds CBP, a CREB binding protein, and synergistically activate transcription. Gene to Cell 2001, 6(10):857-868. 10.1046/j.1365-2443.2001.00469.x.
39. Nioi P., Nguyen T., Sherratt P.J., Pickett C.B. The carboxy terminal Neh3 domain of Nrf2 is required for transcriptional activation. Molecular and Cellular Biology 2005, 25(24):10895-10906. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.25.24.10895-10906.2005.
40. Ogura T., Tong K.I., Mio K., Maruyama Y., Kurokawa H., Sato C., Yamamoto M. Keap1 is a forked stem dimer structure with two large spheres enclosing the intervening DGR and C-terminal domains. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(7):2842-2847. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.0914036107.
41. Lo S.C., Li X., Henzl M.T., Beamer L.J., Hannink M. Structure of Keap1-Nrf2 interface provides mechanistic insight into Nrf2 signalling. EMBO Journal 2006, 25(15):3605-3617.
42. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environment stresses via the Keap1-Nrf2 ARE pathway. Annual Review of Pharmacology and Toxicology 2007, 47:89-116. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1146/annurev.pharmtox.46.120604.141046.
43. Adams J., Kelso R., Cooley L. ReviewThe Kelch repeats superfamily of proteins: propellers of cell function. Trends in Cell Biology 2000, 10(1):17-24. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0962-8924(99)01673-6.
44. Kobayashi M., Li L., Iwamoto N., Nakajima-Takagi Y., Kaneko H., Nakayama Y., et al. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Molecular and Cellular Biology 2009, 29(2):493-502. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.01080-08.
45. Zhang D.D., Hannink M. Distinct cysteine residue in keap1 are required for keap1 dependent ubiquitination of Nrf2 and for stabilisation of Nrf2 by chemopreventive agents and oxidative stress. Molecular and Cellular Biology 2003, 23(22):8137-8151. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.23.22.8137-8151.2003.
46. Karapetian R.N., Evstafieva A.G., Abaeva I.S., Chichkova N.V., Filonov G.S., et al. Nuclear oncoprotein prothymosin α is a partner of Keap1: implications for expression of oxidative stress protecting genes. Molecular and Cellular Biology 2005, 25(3):1089-1099. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.25.3.1089-1099.2005.
47. Nguyen T., Sherratt P.J., Nioi P., Yang C.S., Pickett C.B. Nrf2 controls constitutiveand inducible expression of ARE driven genes through a dynamic pathway involve nucleocytoplasmic shuttling by Keap1. Journal of Biological Chemistry 2005, 280(37):32485-32492. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M503074200.
48. Velichkova M., Hasson T. Keap1 regulates oxidative sensitive shuttling of Nrf2 into and out of nucleus via Crm-1 dependent nuclear export mechanism. Molecular and Cellular Biology 2005, 25(11):4501-4513. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.25.11.4501-4513.2005.
49. Kang M.I., Kobayashi A., Wakabayashi N., Kim S.G., Yamamoto M. Scaffolding of Keap1 to actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(7):2046-2051. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.0308347100.
50. Hudson A.M., Cooley L. Drosophila Kelch filament with Cullin-3 to organize the ring canal actin cytoskeleton. Journal of Cell Biology 2010, 188(1):29-37. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1083/jcb.200909017.
51. Kang K.W., Lee S.J., Park J.W., Kim S.G. Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2 related factor 2 through actin rearrangement in response to oxidative stress. Molecular Pharmacology 2002, 62(5):1001-1010. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1124/mol.62.5.1001.
52. Bloom D.A., Jaiswal A.K. Phosphorylation of Nrf2 at Ser 40 by PKC in response to antioxidant leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilisation/accumulation in nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:Quinone oxidoreductase 1-gene expression. Journal of Biological Chemistry 2003, 278(45):44675-44682. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M307633200.
53. Huang H.C., Nguyen T., Cecil B.P. Phosphorylation of Nrf2 at ser-40 by PKC regulates antioxidant response element-mediated transcription. Journal of Biological Chemistry 2002, 277(45):42769-42774. 10.1074/jbc.M206911200.
54. Niture S.K., Jain A.K., Jaiswal A.K. Antioxidant induced modification of INrf2 cysteine 151 and PKC-delta mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. Journal of Cell Science 2009, 122(24):4452-4464. 10.1242/jcs.058537.
55. Hong F., Sekhar K.R., Freeman M.L., Liebler D.C. Specific pattern of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. Journal of Biological Chemistry 2005, 280(36):31768-31775. 10.1074/jbc.M503346200.
56. Theodore M., Kawai Y., Yang J., Kleshchenko Y., Reddy S.P., et al. Multiple nuclear localisation signals function in nuclear import of transcription factor Nrf2. Journal of Biological Chemistry 2008, 283(14):8984-8994. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M709040200.
57. Jain A.K., Bloom D.A., Jaiswal A.K. Nuclear import and export signals in control of Nrf2. Journal of Biological Chemistry 2005, 280(32):29158-29168. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M502083200.
58. Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2: INrf2 (Keap1) signaling in oxidative stress. Free Radiac. Biologische Medizin 2009, 47(9):1304-1309.
59. Zipper L.M., Mulcahy R.T. The Keap BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. Journal of Biological Chemistry 2002, 277(39):36544-36552. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M206530200.
60. Li W., Yu S.W., Kong A.N. Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. Journal of Biological Chemistry 2006, 281(37):27251-27263. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M602746200.
61. Zhang D.D. Mechanistic studies of Nrf2-Keap1 signaling pathway. Drug Metabolism Reviews 2006, 38(4):769-789. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1080/03602530600971974.
62. Sun Z., Zhang S., Chan J.Y., Zhang D.D. Keap1 controls post-induction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Molecular and Cellular Biology 2007, 27(18):6334-6349. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.00630-07.
63. Sun Z., Wu T., Zhao F., Lau A., Birch C.M., Zhang D.D. KPNA6 (Importin-α7) mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response. Molecular and Cellular Biology 2011, 31(9):1800-1811. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.05036-11.
64. Jain A.K., Jaiswal A.K. GSK-3β acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. Journal of Biological Chemistry 2007, 282(22):16502-16510. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M611336200.
65. Kaspar J.W., Jaiswal A.K. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB Journal: Official Publication of the Federation of American Societies For Experimental Biology 2011, 25(3):1076-1087. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1096/fj.10-171553.
66. Kanninen K., White A.R., Koistinaho J., Malm T. Review "targeting glycogen synthase kinase-3β for therapeutic benefit against oxidative stress in Alzheimer's disease: involvement of the Nrf2-ARE pathway". International Journal of Alzheimer's Disease 2011, 2011(985085):9. 10.4061/2011/985085.
67. Li W., Yu S., Liu T., Kim J.H., Blank V., Li H., Kong A.N. Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NES zip motif. Biochemica et Biophysica Acta 2008, 1783(10):1847-1856. http://dx.doi.org/10.1016/j.bbamcr.2008.05.024.
68. Kasper J.W., Jaiswal A.K. An Auto-regulatory Loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance. Journal of Biological Chemistry 2010, 285(28):21349-21358. 10.1074/jbc.M110.121863.
69. Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biology 2013, 1(1):45-49. http://www.ncbi.nlm.nih.gov/pubmed/.
70. Niture S.K., Jaiswal A.K. Nrf2 protein upregulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. Journal of Biological Chemistry 2012, 287(13):9873-9886. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M111.312694.
71. Wang X.J., Sun Z., Villeneuve N.F., Zhang S., Zhao F., Li Y., et al. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 2008, 29(6):1235-1243. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1093/carcin/bgn095.
72. Niture S.K., Jaiswal A.K. INrf2 (Keap1) targets Bcl2 degradation and controls cellular apoptosis. Cell Death and Differentiation 2011, 18(3):439-451. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/cdd.2010.114.
73. Sebens S., Bauer I., Geismann C., Grage-Griebenow E., Ehlers S., et al. Inflammatory macrophages induce Nrf2 transcription factor dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection. Journal of Biological Chemistry 2011, 286(47):40911-40921. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M111.274902.
74. Narasimhan M., Mahimainathan L., Rathinam M.L., Riar A.K., Henderson G.I. Overexpression of Nrf2 protects cerebral cortical neurons from ethanol-induced apoptotic death. Molecular Pharmacology 2011, 80(6):988-999. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1124/mol.111.073262.
75. Maher J.M., Dieter M.Z., Aleksunes L.M., Slitt A.L., Guo G., Tanaka Y., Scheffer G.L., et al. Oxidative and electrophilic stress induces multidrug resistance-associated protein (MRP1) transporters via the nuclear factor E2 related factor 2 transcriptional pathway. Hepatology (Baltimore, Md.) 2007, 46(5):1597-1610. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/hep.21831.
76. Ji L., Li H., Gao P., Shang G., Zhang D.D., Zhang N., Jiang T. Nrf2 pathway regulates multidrug-resistance-associated Protein 1 (MRP1) in small cell lung cancer. PLOS One 2013, 8(5):e63404. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1371/journal.pone.0063404.
77. Lieber M.R. The mechanism of human non-homologous DNA end joining. Journal of Biological Chemistry 2008, 283(1):1-5. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.R700039200.
78. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., Weitzmann M.D. The Mre11 complex is required for ATM activation and G2/M checkpoint. EMBO Journal 2003, 22(24):6610-6620.
79. Mirzoeva O.K., Petrini J.H. DNA damage dependent nuclear dynamics of Mre11 complex. Molecular and Cellular Biology 2001, 21(1):281-288. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.21.1.281-288.2001.
80. Moore J.K., Haber J.E. Cell cycle and genetic requirements of two pathways of non-homologous end joining repair of double strands breaks in Saccharomyces cerevisiae. Molecular and Cellular Biology 1996, 16(5):2164-2173. http://www.ncbi.nlm.nih.gov/pubmed/.
81. Alani E., Padmore R., Kleckner N. Analysis of wild type and Rad50 mutant of yeast suggests an intimate relationship between meiotic chromosome synapsis and recombination. Cell 1990, 61(3):419-436. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/0092-8674(90)90524-I.
82. Bala M. Radiation induced radioresistance- Role of DNA repair and mitochondria. Gamma Radiation 2012, 149-170. InTech, Croatia. F. Adrovic (Ed.).
83. Zhu J., Petersen S., Tessarollo L., Nussenzweig A. Targeted disruption of NBS1 leads to early embryonic lethality in mice. Current Biology 2001, 11(2):105-109. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0960-9822(01)00019-7.
84. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., Petrini J.H. Disruption of mRad50 causes embryonic stem cells lethality abnormal embryonic development and sensitivity to ionizing radiation. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(13):7376-7381. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.96.13.7376.
85. Xiao Y., Weaver D.T. Conditional gene targeted deletion by Cre recombinase demonstrate the requirement for the double strands break repair MRE11 protein in murine embryonic stem cells. Nucleic Acids Research 1997, 25(15):2985-2991. 10.1093/nar/25.15.2985.
86. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double stranded breaks induce histone H2AX phosphorylation on ser-139. Journal of Biological Chemistry 1998, 273(10):5858-5868. 10.1074/jbc.273.10.5858.
87. Sedelnikova O.A., Rogakou E.P., Panyutin I.G., Bonner W.M. Quantitative detection of 125IdU induced DNA double strands break with gamma H2AX antibody. Radiation Research 2002, 158(4):486-492. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2.
88. Desai-Mehta A., Cerosaletti K.M., Concannon P. Distinct functional domains of nibrin mediates Mre11 binding, focus formation and nuclear localisation. Molecular and Cellular Biology 2001, 21(6):2184-2191. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1128/MCB.21.6.2184-2191.2001.
89. Jazayeri A., Balestrini A., Garner E., Haber J.E., Costanzo V. Mre11-Rad50-Nbs1 dependent processing of DNA breaks generates oligonucleotides that stimulates ATM activity. EMBO Journal 2008, 27(14):1953-1962.
90. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421(6922):499-506. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/nature01368.
91. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., et al. ATM and ATR substrate analysis reveals extensive protein networks responsible to DNA damage. Science (New York, N.Y.) 2007, 316(5828):1160-1166. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1126/science.1140321.
92. Cedervall B., Wong R., Albright N., Dynlacht J., Lambin P., Dewey W.C. Methods for quantification of DNA double stands breaks determined from the distribution of DNA fragment sizes measurement by PFGE. Radiation Research 1995, 143(1):8-16. http://www.ncbi.nlm.nih.gov/pubmed/, 10.2307/3578920.
93. Pizarro J.G., Folch J., Vazquez De la Torre A., Verdaguer E., Junyent F., Jordán J., et al. Oxidative stress induced DNA damage and cell cycle regulation in B65 dopaminergic cell line. Free Radical Research 2009, 43(10):985-994. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1080/10715760903159188.
94. Stolz A., Ertych N., Bastians H. Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research 2011, 17:401-405. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1158/1078-0432.CCR-10-1215.
95. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science (New York, N.Y.) 2000, 287(5459):1824-1827. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1126/science.287.5459.1824.
96. Xu Y., Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes and Development 1996, 10(19):2401-2410. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1101/gad.10.19.2401.
97. Jack M.T., Woo R.A., Hirao A., Cheung A., Mak T.W., Lee P.W. Chk2 is dispensable for p53 mediated G1 arrest but is required for latent p53 mediated apoptotic response. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(15):9825-9829. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.152053599.
98. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(16):7491-7495. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.89.16.7491.
99. Nakano K., Balint E., Ashcroft M., Vousden K.H. A ribonucleotide reductase gene is a transcription target of p53 and p73. Nature 2000, 19(37):4283-4289.
100. Samali A., Nordgren H., Zhivotovsky B., Peterson E., Orrenius S. A comparative study of apoptosis and necrosis in Hep G2 cells: oxidant induced caspase inactivation leads to necrosis. Biochemical and Biophysic Research Communications 1999, 255(1):6-11. 10.1006/bbrc.1998.0139.
101. Rendon-Mitchell B., Ochani M., Li J., Han J., Wang H., Yang H., Susarla S., et al. IFN- induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950) 2003, 170(7):3890-3897. http://www.ncbi.nlm.nih.gov/pubmed/.
102. Wang H., Vishnubhakat J.M., Bloom O., Zhang M., Ombrellino M., Sama A., Tracey K.J. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126(2):389-392. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0039-6060(99)70182-0.
103. Wu X., Mi Y., Yang H., Zhang Q., Shang C. The activation of HMGB1 as a progression factor on inflammation response in normal bronchial epithelial cells through RAGE/JNK/NF-kB pathway. Molecular and Cellular Biochemistry 2013, 380(1-2):249-257.
104. Bala M., Prasad J., Singh S., Tiwari S., Sawhney R.C. Whole body radioprotective effects of SBL-1:a preparation from leaves of Hippophae rhamnoides. Journal of Herbs Spicesand Medicinal plants 2009, 15:203-215. 10.1080/10496470903139496.
105. Tiwari S., Arya A., Tyagi S., Prasad J., Singh S., Vats P., Kumar D., Jain S.K., Bala M. Antioxidant, anti-mutagenic and radioprtotective properties of sea buckthorn leaf (Hippophae rhamnoides L.). Journal of Medicinal and Spice Plants 2009, 14(2):83-89.
106. Tiwari S., Bala M. Hippophae leaves prevent immunosuppression and inflammation in 60 Co-γ-irradiated mice. Phytopharmacology 2011, 1(3):36-48.
107. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science (New York, N.Y.) 1999, 285(5425):248-251. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1126/science.285.5425.248.
108. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. Journal of Experimental Medicine 2000, 192(4):565-570. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1084/jem.192.4.565.
109. Popovic K., Ek M., Espinosa A., Padyukov L., Harris H.E., et al. Increased expression of novel pro-inflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis and Rheumatism 2005, 52(11):3639-3645. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/art.21398.
110. Taniguchi N., Kawahara K., Yone K., Hashiguchi T., Yamakuchi M., Goto M., et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis and Rheumatism 2003, 48:971-981. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/art.10859.
111. Evankovich J., Cho S.W., Zhang R., Cardinal J., Dhupar R., Zhang L., et al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased HDAC activity. Journal of Biological Chemistry 2010, 285(51):39888-39897. 10.1074/jbc.M110.128348P.
112. Tang D., Kang R., Zeh H.J., Lotze M.T. High mobility group box-1, oxidative stress and disease. Antioxidants and Redox Signaling 2011, 14(7):1315-1335. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1089/ars.2010.3356.
113. Zandarashvili L., Sahu D., Lee K., Lee Y.S., Singh P., Rajarathnam K., Iwahara J. Real time kinetics of high mobility group box (HMGB1) oxidation in extra-cellular fluids studied by in situ protein NMR spectroscopy. Journal of Biological Chemistry 2013, 288(17):11621-11627. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M113.449942.
114. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. Journal of Cell Biology 2004, 164(3):441-449. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1083/jcb.200304135.
115. Liu A., Fang H., Dirsch O., Jin H., Dahmen U. Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion. PLOS One 2012, 7(4):e35379. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1371/journal.pone.0035379.
116. Yang H., Lundbäck P., Ottosson L., Erlandsson-Harris H., Venereau E., Bianchi M.E. Redox modification of cysteine residues regulates the cytokines activity of HMGB1. Molecular Medicine 2012, 18(1):250-259.
117. Loukili N., Rosenblatt-Velin N., Li J., Clerc S., Pacher P., Feihl F., Waeber B., Liaudet L. Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infracted myocardium in vivo. Cardiovascular Research 2011, 89(3):586-594. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1093/cvr/cvq373.
118. Xu D., Young J., Song D., Esko J.D. Heparan sulphate is essential for high mobility group protein 1 (HMGB1) signalling by the receptor for advanced glycation end products (RAGE). Journal of Biological Chemistry 2011, 286(48):41736-41744. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.M111.299685.
119. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101(7):2652-2660. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1182/blood-2002-05-1300.
120. Li W., Sama A.E., Wang H. Role of HMGB1 in cardiovascular diseases. Current Opinion in Pharmacology 2006, 6(2):130-135. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.coph.2005.10.010.
121. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB Journal : Official Publication of the Federation of American Societies For Experimental Biology 1997, 11(6):457-465. http://www.ncbi.nlm.nih.gov/pubmed/.
122. Bussolino F., Wang J.M., Defilippi P., Turrini F., Sanavio F., Edgell C.J., et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337(6206):471-473. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/337471a0.
123. Slavin J. Fibroblast growth factors: At the heart of angiogenesis. Cell Biology International 1995, 19(5):431-444. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1006/cbir.1995.1087.
124. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (New York, N.Y.) 1989, 246(4935):1306-1309. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1126/science.2479986.
125. Lynch C.N., Wang Y.C., Lund J.K., Chen Y.W., Leal J.A., Wiley S.R. TWEAK induces angiogenesis and proliferation of endothelial cells. Journal of Biological Chemistry 1999, 274(13):8455-8459. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.274.13.8455.
126. Desplat-Jégo S., Varriale S., Creidy R., Terra R., Bernard D., Khrestchatisky M., et al. TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. Journal of Neuroimmunology 2002, 133(1-2):116-123. http://www.ncbi.nlm.nih.gov/pubmed/.
127. Harada N., Nakayama M., Nakano H., Fukuchi Y., Yagita H., Okumura K. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 2002, 299(3):488-493. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S0006-291X(02)02670-0.
128. Jakubowski A., Browning B., Lukashev M., Sizing I., Thompson J.S., et al. Dual role for TWEAK in angiogenic regulation. Journal of Cell Science 2002, 115(2):267-274. http://www.ncbi.nlm.nih.gov/pubmed/.
129. Wilson C.A., Browning J.L. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death and Differentiation 2002, 9(12):1321-1333. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.cdd.4401107.
130. Kaplan M.J., Lewis E.E., Shelden E.A., Somers E., Pavlic R., McCune W.J., et al. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. Journal of Immunology (Baltimore, Md. : 1950) 2002, 169(10):6020-6029. http://www.ncbi.nlm.nih.gov/pubmed/.
131. Chicheportiche Y., Bourdon P.R., Xu H., Hsu Y.M., Scott H., Hession C. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. Journal of Biological Chemistry 1997, 272(51):32401-32410. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1074/jbc.272.51.32401.
132. Donohue P.J., Richards C.M., Brown S.A., Hanscom H.N., Buschman J., Thangada S., et al. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23(4):594-600. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/01.ATV.0000062883.93715.37.
133. Felli N., Pedini F., Zeuner A., Petrucci E., Testa U., Conticello C., et al. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. Journal of immunology (Baltimore, Md. : 1950) 2005, 175(3):1464-1472. http://www.ncbi.nlm.nih.gov/pubmed/.
134. Nakayama M., Kayagaki N., Yamaguchi N., Okumura K., Yagita H. Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity. Journal of Experimental Medicine 2000, 192(9):1373-1380. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1084/jem.192.9.1373.
135. Maecker H., Varfolomeev E., Kischkel F., Lawrence D., LeBlanc H., Lee W., et al. TWEAK attenuates the transition from innate to adaptive immunity. Cell 2005, 123(5):931-944. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.cell.2005.09.022.
136. Winkles J.A. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nature Reviews Drug Discovery 2008, 7(5):411-425. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/nrd2488.
137. Wiley S.R., Winkles J.A. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokineand Growth Factor Reviews 2003, 14(3-4):241-249. http://www.ncbi.nlm.nih.gov/pubmed/.
138. Nakayama M., Ishidoh K., Kojima Y., Harada N., Kominami E., Okumura K., et al. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK induced cell death. Journal of immunology (Baltimore, Md. : 1950) 2003, 170(1):341-348. http://www.ncbi.nlm.nih.gov/pubmed/.
139. Zhu L.X., Zhang H.H., Mei Y.F., Zhao Y.P., Zhang Z.Y. Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases. Chinese Medical Journal 2012, 125(21):3898-3904. http://www.ncbi.nlm.nih.gov/pubmed/.
140. Moreno J.A., Sastre C., Madrigal-Matute J., Muñoz-García B., Ortega L., Burkly L.C., et al. HMGB1 expression and secretion are increased via tweak Fn-14 interaction in atherosclerotic plaques and cultured monocytes. Arteriosclerosis, Thrombosis, and Vascular Biology 2013, 33(3):612-620. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1161/ATVBAHA.112.300874.
141. Bala M, Tiwari S, Prasad J, Singh S Herbal preparation from Seabuckthorn (Hippophae L.) renders survival benefit, protects hematopoietic and liver stem cells in whole body irradiated mice. Seabuckthorn (Hippophae L.)-A Multipurpose Wonder Plant, Vol. IV: Emerging Trends in Research and Technologies 2014, 370-381. Daya Publishing House® , A Division of Astral International Pvt. Ltd., New Delhi-110002. V. Singh (Ed.).
142. Ho D.H., Vu H., Brown S.A., Donohue P.J., Hanscom H.N., Winkles J.A. Soluble tumor necrosis factor like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice. Cancer Research 2004, 64(24):8968-8972. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1158/0008-5472.CAN-04-1879.
143. Wiley S.R., Cassiano L., Lofton T., Davis-Smith T., Winkles J.A., Lindner V., Liu H., et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 2001, 15(5):837-846. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/S1074-7613(01)00232-1.
144. Prasad C.V.S., Bala M. Exploring in silico affinity of flavonoids and tannins to human fibroblast growth factor inducible14 (Fn14), a member of TNF receptor super family. Bioinformation 2013, 9(12):633-638.
145. Nowsheen S., Yang E.S. The intersection between DNA damage response and cell death pathways. Experimental Oncology 2012, 34(3):243-254. http://www.ncbi.nlm.nih.gov/pubmed/.
146. Mauro M., Rego M.A., Boisvert R.A., Esashi F., Cavallo F., Jasin M., Howlett N.G. p21 promotes error-free replication-coupled DNA double-strand break repair. Nucleic Acids Research 2012, 40(17):8348-8360. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1093/nar/gks612.
147. Chen W., Sun Z., Wang X.J., Jiang T., Huang Z., Fang D., Zhang D.D. Direct interaction between Nrf2 and p21cip/waf1 upregulates the Nrf2 mediated antioxidant response. Molecular and Cell 2009, 34(6):633-673.
148. Villeneuve N.F., Sun Z., Chen W., Zhang D.D. Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle (Georgetown, Tex.) 2009, 8(20):3255-3256. http://www.ncbi.nlm.nih.gov/pubmed/, 10.4161/cc.8.20.9565.
149. Reddy N.M., Kleeberger S.R., Bream J.H., Fallon P.G., Kensler T.W., Yamamoto M., et al. Genetic disruption of NRf2 comprises cell cycle progression by impairing GSH-induced redox signalling. Oncogene 2008, 27(44):5821-5832. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/onc.2008.188.
150. Tang C., Bi M., Yu H., Chen W., Wang J. Zerumbone protects HEK 293 cells from irradiation induced DNA damage via activating Keap1 pathway. African Journal of Pharmacy and Pharmacology 2011, 5(20):2247-2254.
151. Innes L.C., Hesse J.E., Palii S.S., Helmink B.A., Holub E.J., et al. DNA damage activates a complex transcriptional response in murine lymphocytes that includes both physiological and cancer predisposition program. BMC Genomics 2013, 14(1):163. 10.1186/1471-2164-14-163.
152. Kim S.B., Pandita R.K., Eskiocak U., Ly P., Kaisani A., Kumar R., Cornelius C., et al. Targeting of Nrf2 induces DNA damage signalling and protects colonic epithelial cells from ionizing radiation. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(43):E2949-E2955. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1073/pnas.1207718109.
153. Chen X.L., Dodd G., Thomas S., Zhang X., Wasserman M.A., Rovin B.H., Kunsch C. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. American Journal of Physiology-Heart and Circulatory Physiology 2006, 290(5):H1862-H1870. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1152/ajpheart.00651.2005.
154. Kim J.H., Choi Y.K., Lee K.S., Cho D.H., Baek Y.Y., Lee D.K., et al. Functional dissection of Nrf2 dependent phase II gene in vascular inflammation and endotoxic injury using Keap1 SiRNA. Free Radical Biology and Medicine 2012, 53(3):629-640. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1016/j.freeradbiomed.2012.04.019.
155. Pan H., Wang H., Wang X., Zhu L., Mao L. The absence of Nrf2 enhances NF-kB dependent inflammation following scratch injury in mouse primary cultured astrocytes. Mediators of Inflammation 2012, 2012:9. 10.1155/2012/217580.
156. KawaHara K., Hashiguchi T., Masuda K., Saniabadi A.R., Kikuchi K., et al. Mechanism of HMGB1 release inhibition from RAW 264.7 cells by oleanolic acid in prunus mume Sieb et. Zucc. International Journal of Molecular Medicine 2009, 23(5):615-620. http://www.ncbi.nlm.nih.gov/pubmed/.
157. Jun M.S., Kim H.S., Kim Y.M., Kim H.J., Park E.J., Lee J.H., et al. Ethanol extract of Prunella vulgaris var. lilacina inhibits HMGB1 release by induction of HO-1 in LPS activated RAW 264.7 and CLP-induced septic mice. Phytotherapy Research 2012, 26(4):605-612. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1002/ptr.3613.
158. Lee D., Bae J., Kim Y.K., Gil M., Lee J.Y., Park C.S., Lee K.J. Inhibitory effects of berberine on LPS-induced inducible nitric oxide synthase and the HMGB1 release in macrophages. Biochemical and Biophysical Research Communications 2013, 431(3):506-511.
159. Kim H.S., Park E.J., Kim Y.M., Park S.W., Kim H.J., et al. Heme oxygenase-1 induction through p38 MAPK/Nrf2 activation by ethanol extract of Artemisia capillaries inhibits LPS activated iNOS, COX-2 and HMGB1 in RAW 264.7 cells. Phytopharmacology 2013, 4(3):468-480.